Page last updated: 2024-08-25

atovaquone and Chronic Illness

atovaquone has been researched along with Chronic Illness in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (50.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amani, A; Azami, SJ; Faramarzi, MA; Keshavarz, H; Mahmoudi, M; Mohebali, M; Najafi-Taher, R; Shojaee, S1
Abdel-Aziz, A; Azab, MS; El-Tantawy, NL; Elmehankar, MS; Hegazy, MM1
Dezube, BJ; Kirby, JE; Konstantinopoulos, PA; Miller, KB1
Irwin, PJ; Jardine, J; Jefferies, R; Robertson, ID; Ryan, UM1
Araujo, FG; Ferguson, DJ; Huskinson-Mark, J; Remington, JS1
Gormley, PD; Lightman, S; Minnasian, D; Pavesio, CE1
Aumjaud, Y; Derouin, F; Fessi, H; Sordet, F1
Gray, JS; Pudney, M1

Other Studies

8 other study(ies) available for atovaquone and Chronic Illness

ArticleYear
Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, May-30, Volume: 117

    Topics: Acute Disease; Animals; Anti-Infective Agents; Atovaquone; Chronic Disease; Emulsions; Female; Grape Seed Extract; HeLa Cells; Humans; Mice, Inbred BALB C; Nanostructures; Toxoplasma; Toxoplasmosis

2018
Sex dichotomy in the course of experimental latent toxoplasmosis.
    Experimental parasitology, 2019, Volume: 202

    Topics: Animals; Antibodies, Protozoan; Atovaquone; Brain; Chronic Disease; Coccidiostats; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Immunoglobulin G; Interleukin-12; Male; Metronidazole; Mice; Morbidity; Sex Factors; Spiramycin; Testosterone Propionate; Toxoplasma; Toxoplasmosis, Animal

2019
Babesiosis masquerading as recurrent immune thrombocytopenic purpura in a splenectomized patient.
    Annals of hematology, 2006, Volume: 85, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Protozoan; Antimalarials; Atovaquone; Azithromycin; Babesiosis; Chronic Disease; Erythrocyte Inclusions; False Positive Reactions; Female; Humans; Immunoglobulin G; Immunoglobulin M; Platelet Count; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy

2006
Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
    Experimental parasitology, 2007, Volume: 117, Issue:2

    Topics: Acute Disease; Animals; Anti-Infective Agents; Antibodies, Protozoan; Atovaquone; Azithromycin; Babesia; Babesiosis; Chronic Disease; DNA, Protozoan; Dog Diseases; Dogs; Drug Resistance; Female; Fluorescent Antibody Technique; Parasitemia; Polymerase Chain Reaction

2007
An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii.
    International journal of experimental pathology, 1994, Volume: 75, Issue:2

    Topics: Animals; Antiprotozoal Agents; Atovaquone; Brain; Chronic Disease; Female; Mice; Mice, Inbred CBA; Microscopy, Electron; Naphthoquinones; Toxoplasmosis, Animal; Toxoplasmosis, Cerebral

1994
Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease.
    Investigative ophthalmology & visual science, 1998, Volume: 39, Issue:7

    Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Atovaquone; Brain; Chorioretinitis; Chronic Disease; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Female; Mesocricetus; Naphthoquinones; Retina; Toxoplasma; Toxoplasmosis, Cerebral; Toxoplasmosis, Ocular

1998
Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis.
    Parasite (Paris, France), 1998, Volume: 5, Issue:3

    Topics: Acute Disease; Administration, Oral; Animals; Antiprotozoal Agents; Atovaquone; Brain; Capsules; Chronic Disease; Colloids; Disease Models, Animal; Drug Carriers; Drug Stability; Female; Lung; Mice; Naphthoquinones; Parasitemia; Solubility; Survival Rate; Suspensions; Temperature; Toxoplasma; Toxoplasmosis, Animal

1998
Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    The Journal of parasitology, 1999, Volume: 85, Issue:4

    Topics: Acute Disease; Animals; Antiprotozoal Agents; Atovaquone; Babesiosis; Chronic Disease; Clindamycin; Diminazene; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Gerbillinae; Humans; Imidocarb; Naphthoquinones; Pentamidine; Recurrence

1999